Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Int Psychogeriatr ; 17(4): 689-98, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16271159

ABSTRACT

BACKGROUND: Platelet hyper-aggregability is an important risk factor for leukoaraiosis. In this study we investigated whether aggravation of leukoaraiosis can be controlled by means of long-term correction of platelet hyper-aggregability. METHODS: Twenty-one patients with leukoaraiosis and uncorrected platelet hyper-aggregability were compared with 21 controls matched for age, grade of leukoaraiosis and observation period whose platelet hyper-aggregability was corrected. Platelet aggregability was estimated by an optical analytical method with a nine-stage display using two different concentrations each of adenosine diphosphate (ADP) and collagen (the double ADP method). RESULTS: The mean observation period between two magnetic resonance imaging (MRI) scans for both groups was 4.1 years. In the non-corrected group, moderate to severe aggravation of leukoaraiosis was observed in a large number of patients. In the corrected group, only a small number of patients showed generally mild aggravation of leukoaraiosis. The number of patients showing aggravation of periventricular hyperintensity (PVH) was 7 in 21 in the non-corrected group versus 1 in 21 (p = 0.022) in the corrected group, and for aggravation of deep white-matter hyperintensity, these values were 9 in 21 versus 4 in 21, respectively. Thus, the difference was more significant if the degree of aggravation was taken into account. CONCLUSION: The progress of leukoaraiosis is greatly inhibited by long-term correction of platelet hyper-aggregability.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Aspirin/therapeutic use , Leukoaraiosis/drug therapy , Leukoaraiosis/physiopathology , Platelet Aggregation Inhibitors/therapeutic use , Aged , Antihypertensive Agents/therapeutic use , Brain/pathology , Brain/physiopathology , Dementia, Vascular/epidemiology , Dementia, Vascular/prevention & control , Diabetes Mellitus/epidemiology , Female , Humans , Hypercholesterolemia/epidemiology , Hypertension/complications , Hypertension/drug therapy , Leukoaraiosis/epidemiology , Magnetic Resonance Imaging , Male , Obesity/epidemiology , Risk Factors , Tobacco Use Disorder/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...